Naprelan
NDC 24979-250, Naproxen Sodium, tablet, film coated, extended release, from Upsher-Smith Laboratories, LLC.
- Product NDC
- 24979-250
- Status
- Listed
- Labeler
- Upsher-Smith Laboratories, LLC
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA020353
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/24979-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- NAPROXEN SODIUM500 mg/1
Pharmacologic classes
Anti-Inflammatory Agents, Non-Steroidal [CS]; Cyclooxygenase Inhibitors [MoA]; Nonsteroidal Anti-inflammatory Drug [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 24979-250-68 | 24979025068 | 75 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (24979-250-68) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b8a51c9a-488e-4377-a041-436f6a2f8893
Use it
Look up 24979-250 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/24979-250 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 24979-250. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.